Slingshot members are tracking this event:
Gelesis (PTCHF) Expects Readout of Pivotal Trial GLOW in H1 2017 Evaluating Gelesis100 in Weight Loss in Overweight and Obese Subjects With and Without Type 2 Diabetes
- Source Link:
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Sep 25, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Pivotal Trial, Glow, Gelesis100, Weight Loss, Overweight, Obese Subjects, Type 2 Diabtetes, Prediabetic Patients